• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外基质在肺气肿发病机制和治疗中的作用。

The Role of the Extracellular Matrix in the Pathogenesis and Treatment of Pulmonary Emphysema.

机构信息

School of Pharmacy and Allied Health Sciences, St John's University, Queens, NY 11439, USA.

出版信息

Int J Mol Sci. 2024 Oct 2;25(19):10613. doi: 10.3390/ijms251910613.

DOI:10.3390/ijms251910613
PMID:39408941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11477147/
Abstract

Pulmonary emphysema involves progressive destruction of alveolar walls, leading to enlarged air spaces and impaired gas exchange. While the precise mechanisms responsible for these changes remain unclear, there is growing evidence that the extracellular matrix plays a critical role in the process. An essential feature of pulmonary emphysema is damage to the elastic fiber network surrounding the airspaces, which stores the energy needed to expel air from the lungs. The degradation of these fibers disrupts the mechanical forces involved in respiration, resulting in distension and rupture of alveolar walls. While the initial repair process mainly consists of elastin degradation and resynthesis, continued alveolar wall injury may be associated with increased collagen deposition, resulting in a mixed pattern of emphysema and interstitial fibrosis. Due to the critical role of elastic fiber injury in pulmonary emphysema, preventing damage to this matrix component has emerged as a potential therapeutic strategy. One treatment approach involves the intratracheal administration of hyaluronan, a polysaccharide that prevents elastin breakdown by binding to lung elastic fibers. In clinical trials, inhalation of aerosolized HA decreased elastic fiber injury, as measured by the release of the elastin-specific cross-linking amino acids, desmosine, and isodesmosine. By protecting elastic fibers from enzymatic and oxidative damage, aerosolized HA could alter the natural history of pulmonary emphysema, thereby reducing the risk of respiratory failure.

摘要

肺气肿涉及肺泡壁的进行性破坏,导致气腔扩大和气体交换受损。虽然导致这些变化的确切机制尚不清楚,但越来越多的证据表明细胞外基质在该过程中起着关键作用。肺气肿的一个重要特征是破坏围绕气腔的弹性纤维网络,该网络储存着从肺部排出空气所需的能量。这些纤维的降解破坏了呼吸过程中涉及的机械力,导致肺泡壁膨胀和破裂。虽然最初的修复过程主要包括弹性蛋白的降解和再合成,但持续的肺泡壁损伤可能与胶原沉积增加有关,导致肺气肿和间质纤维化的混合模式。由于弹性纤维损伤在肺气肿中的关键作用,防止这种基质成分的损伤已成为一种潜在的治疗策略。一种治疗方法涉及气管内给予透明质酸,这是一种多糖,通过与肺弹性纤维结合来防止弹性蛋白的分解。在临床试验中,吸入雾化 HA 可减少弹性纤维损伤,这可通过释放弹性蛋白特异性交联氨基酸,即脱氧木糖和异脱氧木糖来衡量。通过保护弹性纤维免受酶和氧化损伤,雾化 HA 可以改变肺气肿的自然病史,从而降低呼吸衰竭的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/013408a0c033/ijms-25-10613-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/3e23c8433676/ijms-25-10613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/3d02121c809a/ijms-25-10613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/46d5c8e0ae39/ijms-25-10613-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/fe0d6d0c4059/ijms-25-10613-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/734ad414568e/ijms-25-10613-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/ea3de0bc0fa0/ijms-25-10613-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/013408a0c033/ijms-25-10613-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/3e23c8433676/ijms-25-10613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/3d02121c809a/ijms-25-10613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/46d5c8e0ae39/ijms-25-10613-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/fe0d6d0c4059/ijms-25-10613-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/734ad414568e/ijms-25-10613-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/ea3de0bc0fa0/ijms-25-10613-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132b/11477147/013408a0c033/ijms-25-10613-g007.jpg

相似文献

1
The Role of the Extracellular Matrix in the Pathogenesis and Treatment of Pulmonary Emphysema.细胞外基质在肺气肿发病机制和治疗中的作用。
Int J Mol Sci. 2024 Oct 2;25(19):10613. doi: 10.3390/ijms251910613.
2
Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysema.雾化透明质酸可限制香烟烟雾诱导的小鼠肺气肿模型中的气腔扩大。
Exp Lung Res. 2005 May;31(4):417-30. doi: 10.1080/01902140590918669.
3
How a test for elastic fiber breakdown products in sputum could speed development of a treatment for pulmonary emphysema.痰液中弹性纤维分解产物的检测如何能加速肺气肿治疗方法的研发。
Med Sci Monit. 2004 Jan;10(1):RA1-4.
4
Therapeutic effects of hyaluronan on smoke-induced elastic fiber injury: does delayed treatment affect efficacy?透明质酸对烟雾诱导的弹性纤维损伤的治疗作用:延迟治疗是否会影响疗效?
Lung. 2011 Feb;189(1):51-6. doi: 10.1007/s00408-010-9271-2. Epub 2010 Dec 14.
5
The relationship between elastin cross linking and alveolar wall rupture in human pulmonary emphysema.人类肺气肿中弹性蛋白交联与肺泡壁破裂之间的关系。
Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L747-L755. doi: 10.1152/ajplung.00284.2022. Epub 2023 Apr 4.
6
The pulmonary matrix, glycosaminoglycans and pulmonary emphysema.肺基质、糖胺聚糖与肺气肿
Connect Tissue Res. 1999;40(2):97-104. doi: 10.3109/03008209909029105.
7
The stumbling block in lung repair of emphysema: elastic fiber assembly.肺气肿肺部修复的绊脚石:弹性纤维组装。
Proc Am Thorac Soc. 2006 Jul;3(5):428-33. doi: 10.1513/pats.200601-009AW.
8
Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema?外源性给予透明质酸能否改善肺气肿患者的呼吸功能?
Chest. 2004 Jan;125(1):288-92. doi: 10.1378/chest.125.1.288.
9
Does lysozyme play a role in the pathogenesis of COPD?溶菌酶在慢性阻塞性肺疾病(COPD)的发病机制中起作用吗?
Med Hypotheses. 2015 Jun;84(6):551-4. doi: 10.1016/j.mehy.2015.02.015. Epub 2015 Mar 2.
10
The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes.博来霉素诱导的肺纤维化中弹性纤维断裂模式可能反映微观结构变化。
Lung. 2017 Feb;195(1):93-99. doi: 10.1007/s00408-016-9956-2. Epub 2016 Oct 19.

引用本文的文献

1
Serum Desmosine Levels Might Be Associated with the Size of Ruptured Cerebral Aneurysms in Patients with Aneurysmal Subarachnoid Hemorrhage-A Preliminary Study.血清去甲胍丁胺水平可能与动脉瘤性蛛网膜下腔出血患者破裂脑动脉瘤的大小相关——一项初步研究。
J Clin Med. 2025 Mar 18;14(6):2056. doi: 10.3390/jcm14062056.
2
Desmosine: The Rationale for Its Use as a Biomarker of Therapeutic Efficacy in the Treatment of Pulmonary Emphysema.异锁链素:将其用作治疗肺气肿疗效生物标志物的理论依据。
Diagnostics (Basel). 2025 Feb 27;15(5):578. doi: 10.3390/diagnostics15050578.

本文引用的文献

1
The Challenges of Spirometric Diagnosis of COPD.慢性阻塞性肺疾病肺功能诊断的挑战。
Can Respir J. 2023 Sep 29;2023:6991493. doi: 10.1155/2023/6991493. eCollection 2023.
2
The relationship between elastin cross linking and alveolar wall rupture in human pulmonary emphysema.人类肺气肿中弹性蛋白交联与肺泡壁破裂之间的关系。
Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L747-L755. doi: 10.1152/ajplung.00284.2022. Epub 2023 Apr 4.
3
Mechanical Properties and Functions of Elastin: An Overview.弹性蛋白的力学性能与功能:概述。
Biomolecules. 2023 Mar 22;13(3):574. doi: 10.3390/biom13030574.
4
Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease.基质金属蛋白酶在慢性阻塞性肺疾病中的作用。
Int J Mol Sci. 2023 Feb 14;24(4):3786. doi: 10.3390/ijms24043786.
5
Oxidative Stress in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中的氧化应激
Antioxidants (Basel). 2022 May 13;11(5):965. doi: 10.3390/antiox11050965.
6
Densification: Hyaluronan Aggregation in Different Human Organs.致密化:透明质酸在不同人体器官中的聚集
Bioengineering (Basel). 2022 Apr 5;9(4):159. doi: 10.3390/bioengineering9040159.
7
Free lung desmosine: a potential biomarker for elastic fiber injury in pulmonary emphysema.游离肺硬朊:肺气肿中弹性纤维损伤的一个潜在生物标志物。
Biomarkers. 2022 Jun;27(4):319-324. doi: 10.1080/1354750X.2022.2043443. Epub 2022 Feb 24.
8
Collagen Biosynthesis, Processing, and Maturation in Lung Ageing.肺衰老过程中的胶原蛋白生物合成、加工与成熟
Front Med (Lausanne). 2021 May 20;8:593874. doi: 10.3389/fmed.2021.593874. eCollection 2021.
9
A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.一项为期 28 天的使用透明质酸作为药物疗效替代标志物的α-1 抗胰蛋白酶缺乏 COPD 患者的雾化吸入临床试验。
Respir Med. 2021 Jun;182:106402. doi: 10.1016/j.rmed.2021.106402. Epub 2021 Apr 14.
10
Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management.肺纤维化合并肺气肿(CPFE)的临床特征和管理。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 28;16:167-177. doi: 10.2147/COPD.S286360. eCollection 2021.